Aurora Cannabis Inc. (NASDAQ:ACB) saw an upside of 5.34% to close Monday at $1.02 after adding $0.05 on the day. The 5-day average trading volume is 7,891,960 shares of the company’s common stock. It has gained $1.0700 in the past week and touched a new high 2 times within the past 5 days. An average of 7,545,325 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 10,834,376.
ACB’s 1-month performance is 8.21% or $0.0930 on its low of $0.8213 reached on 12/28/22. The company’s shares have touched a 52-week low of $0.82 and high of $4.90, with the stock’s rally to the 52-week high happening on 01/18/23. YTD, ACB has achieved 10.56% or $0.0974 and has reached a new high 5 times. However, the current price is down -79.18% from the 52-week high price.
ACB stock has a beta of 2.97. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 1.89 while the price-to-book (PB) in the most recent quarter is 0.55.
Aurora Cannabis Inc.’s quick ratio for the period ended June 29 was 2.90, with the current ratio over the same period at 3.70. As well, the company’s long term debt to equity for the quarter ending June 29 was 0.51, while the total debt to equity was 0.59. In terms of profitability, the gross margin trailing 12 months is -63.80%. The firm’s gross profit as reported stood at $16.77 million against revenue of $174.88 million.
For the quarterly period ending June 29 this year, Net income and sales went down compared to those figures reported in the previous quarter. Analysts expected ACB to announce -$0.15 per share in earnings in its latest quarter, but it posted $0, representing a 100.00% surprise. EBITDA for the quarter stood at more than -$33.61 million. ACB stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 440.89 million, with total debt at $269.49 million.
Let’s look briefly at Aurora Cannabis Inc. (ACB) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 23 January was 58.91% to suggest the stock is trending Neutral, with historical volatility in this time period at 67.01%.
The stock’s 5-day moving average is $0.9867, reflecting a -0.97% or -$0.0100 change from its current price. ACB is currently trading +6.24% above its 20-day SMA, -37.04% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -21.54% and SMA200 by-73.98%.
Stochastic %K and %D was 58.66% and 59.18% and the average true range (ATR) pointed at 0.0653. The RSI (14) points at 52.71%, while the 14-day stochastic is at 77.26% with the period’s ATR at 0.0705. The stock’s 9-day MACD Oscillator is pointing at 0.0136 and 0.0354 on the 14-day charts.
In the most recent analyst report for Aurora Cannabis Inc. (NASDAQ: ACB), Canaccord Genuity upgraded it to a Hold rating. They previously had a Sell rating on the stock. Analysts offering their rating for ACB stock have a consensus rating for the stock as Hold. Currently, 0 brokerage advisors rate ACB as a “sell,”, while 10 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 1 rates the stock as overweight while 1 have offered a “buy” rating.